Funding announcement
A new VC fund backing early-stage medical and healthtech startups is on the hunt for investors
MedTech Actuator alumni are behind Synthesis Capital, a new venture fund courting investors for up to $100m to back young health technology companies across Australia and the Asia-Pacific.